Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Retinol palmitate (1), which is commonly called "Vitamin A palmitate", has been shown to form charge transfer (CT) complexes with a series of electron acceptors including [60]- and [70]fullerenes, and from the trends in CT transition energies the vertical ionization potential of 1 has been estimated to be 7.73eV. Stoichiometries of the fullerene complexes have been shown to be 1(Vitamin 1): 1([70]fullerene) and 1(Vitamin 1): 2([60]fullerene). The enthalpies and entropies of formation of these two complexes have been determined by estimating the formation constants spectrophotometrically at five different temperatures. The complexation phenomenon may be utilised to dissolve the fullerenes in the non-toxic
Vitamin A oil
and the solution may be used for testing the biological activity of the fullerenes in vivo.
Spectrochim Acta A
Mol
Biomol Spectrosc 2005 Apr
PMID:Spectroscopic and thermodynamic study of charge transfer interactions of retinol palmitate with [60]- and [70]fullerenes by absorption spectrometric method. 1574 Nov 31